300573.SZ
Shenyang Xingqi Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 38.52
−3.09%Sep 15, 2026, 07:51 UTC
Shenyang Xingqi Pharmaceutical received a drug clinical trial approval notice from China's National Medical Products Administration for its SQ-25012 injection, allowing clinical trials for treating thyroid eye disease.
Source: